D-1169-2022 Class II Ongoing
FDA drug recall D-1169-2022 was initiated by Noven Pharmaceuticals Inc on Jun 24, 2022 and is designated Class II. Reason for recall: Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer. The recall status is ongoing. Affected quantity: 8,559 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 6, 2022
- Initiation Date
- Jun 24, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,559 cartons
Product description
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC 68968-5552-3
Reason for recall
Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot: 91272 Exp. 12/22.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1169-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026